Eurolyser Diagnostics - Premium Laboratory Equipment

NEW: Immunologic FOB test kit for colorectal cancer screening for smart point of care platform

Wednesday, 10. November 2010

Due to its easy handling and the fact of lowering the mortality quote fhe fecal occult blood (FOB) test is the most common screening test for the colorectal carcinoma at the present. Disadvantages of existing tests are insufficient sensitivity – especially when indicating early stages of the carcinoma – and a low public acceptance.

The new smart point of care immunologic FOB is more specific and more sensitive.

It is based on the detection of human haemoglobin by using specific antiobodies and is therefore indipendent of dietary or medicinal factors resulting in a higher public acceptance. The detection of tumour-DNA in stool by use of the smart FOB test dawns a new area of detecting colorectal carcinoma at an early stage. The full quantitative test enables to detect and display precise concentrations.

Smart FOB test advantages at a glance:

  • immunologic test
  • independent of dietary or medicinal factors
  • full quantitative results
  • early detection of colorectal carcinomas

Eurolyser News

2. December 2014

Eurolyser at Arab Health 2015 in Dubai...
» Read more...

12. November 2014

Significant extension of the CUBE test portfolio...
» Read more...

20. October 2014

Eurolyser in Dusseldorf at the Medica 2014...
» Read more...

8. July 2014

Lipase quick-test for veterinarians now available...
» Read more...